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Tuberculosis (TB) prevalence surveys are recommended in selected high TB burden countries to measure progress towards the Millennium Development Goals and Stop TB Partnership targets, which recommend a 50% reduction in TB prevalence by 2015 compared to the 1990 levels. 1, 2 Prevalence surveys require sample sizes ranging from 20 000 to over 200 000, to estimate the disease burden with sufficient precision and to detect significant reductions 10 years later. Most surveys aim to measure the burden of bacteriologically confirmed pulmonary TB. In settings where performing sputum culture examination on all survey participants is not feasible, a screening strategy including chest radiography (CXR) is recommended to select participants for further bacteriological examination of sputum (usually culture and smear). 3, 4 The recommended practice is that the films be examined in the field by a medical officer 5 , as soon as the CXR has been obtained, and at a later time at central level by two independent expert readers, a radiologist and a chest physician, and by a third in case of discrepancies. 3, 4 In sub-Saharan Africa, although TB rates are high, but professionals qualified to read and interpret CXRs are rare. For logistical and cost purposes it would be useful if other medical personnel could be trained to read the screening CXRs in prevalence surveys with sufficient accuracy so that expert interpretation of the presence of radiographic abnormalities consistent with present or past TB could be limited to a smaller number of CXRs.
We conducted a TB prevalence survey in a rural area in western Kenya. 6 Participants were screened by CXR, symptom questionnaire and sputum microscopy. For CXR screening, clinical officers rather than medical officers were trained by a radiologist to read CXRs at the study enrolment sites and classify those as either normal or abnormal.
We wanted to compare clinical officer and expert classifications, and assess to what extent CXR abnormalities that were missed by the clinical officers may have contributed to underestimation of the reported prevalence 6 .
METHODS

Survey
A TB prevalence survey was conducted between August 2006 and December 2007 in the Asembo (Rarieda District) and Gem District areas in western Kenya, where human immunodeficiency virus (HIV) prevalence is high. 7 The final analysis included 20,566 residents aged ≥15 years from 40 sampled clusters ( Figure 1) . A posterior-anterior chest radiograph (CXR) was taken of 19 216 (93%) participants, in a mobile unit at a nearby location, using a 400 mA / 40 KW X-ray machine, 35 x 43 cm films and automatic film processing. Two sputum samples for microscopy were requested from all participants, and an additional sputum sample for mycobacterial culture was requested from suspects (see definition below). The prevalence of bacteriologically confirmed TB was 6.0 per 1000 (95% confidence interval (CI) 4.6-7.4), and of smear-positive TB 2.5 per 1000 (95%CI 1.6-3.4). HIV testing was requested of prevalent TB cases. Of 101 patients tested, 52 (51%) were HIV-infected.
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Definitions and classifications Suspect: survey participant with either a CXR abnormality and/or symptoms suggestive of TB on interview and/or a positive sputum smear microscopy result.
Confirmed TB case: survey participant with bacteriologically confirmed pulmonary TB:
either one culture sample positive for Mycobacterium tuberculosis, or two sputum smears positive for acid-fast bacilli not explained by positive culture for nontuberculous mycobacteria.
CXR quality rating (applied by experts): 1 = optimal; 2 = suboptimal, but no technical defect likely to impair classification; 3 = suboptimal with some technical defect but still adequate; or 4 = unreadable.
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Readers and training
Three clinical officers with an education level comparable to paramedical and nursing professions, were trained for 2 weeks by a radiologist in assessing CXRs for quality and presence of common abnormalities, and to identify which abnormal conditions required further care. The CXR of a survey participant was reviewed on site on the same day by one clinical officer blinded to participant information other than age and sex. For
CXRs classified as abnormal, the clinical officer indicated whether the abnormality was pulmonary, cardiac, pleural effusion and/or 'other'. The clinical officers rotated, and alternated CXR reading with clinical tasks on site.
Quality assurance and control
The radiographers applied standard quality procedures. 9, 10 After assessment, the five CXRs. To assess inter-and intra-reader variation, the clinical officers also re-read a random sample of 780 CXRs during the survey. These were selected separate from the sample for expert reading and not shown in Figure 1 .
Sample for expert review
From earlier analysis of a non-random sample read by the radiologist (data not shown), agreement. 13 We calculated the sensitivity and specificity of the clinical officers and experts in identifying TB cases by CXR, using the CXRs of bacteriologically confirmed TB cases as the gold standard positives, and the randomly selected CXRs of participants without TB as the negatives (derived at as shown in Figure 1 ).
estimating possibly missed cases
Among the 12 041 non-suspects in the survey who did not have symptoms suggestive of TB, had negative sputum smears and a normal CXR according to the clinical officers, and who were therefore not considered for sputum culture examination, some cases of prevalent TB may have been missed due to CXR abnormalities that were missed by the clinical officers. Additional missed cases due to missing data (sputum samples, CXRs)
were not considered for this calculation.
We compared the clinical officer and expert reports of non-suspects among the randomly selected CXRs, and calculated the proportion of CXRs that were classifi ed as normal by the clinical officers, but as having an abnormality consistent with TB according to one of the experts or both experts. We multiplied the proportions of missed abnormalities consistent with TB by the prevalence of smear-negative, culture-positive TB among participants who did not report symptoms suggestive of TB but whose CXR was classified as 'abnormal' by the clinical officers, assuming that participants for whom CXR abnormalities were missed by the clinical offi cers had a TB prevalence similar to that of participants whose abnormalities were not missed. The 95%CI of the product of the two proportions was calculated according to the Delta method. 14 We then applied these proportions to the 12 041 non-suspects to obtain the number of missed prevalent cases.
Ethical approval
The prevalence survey protocol was approved by the scientific and ethical steering 
RESulTS
The analysis included 1143 CXRs, 1031 were randomly selected among participants without TB, while 112 were of persons identified with bacteriologically confirmed prevalent TB (Figure 1 ). The distribution of CXR abnormalities, symptoms suggestive of TB, suspects and prevalent cases was similar in the random sample and the survey (Table   1 
Agreement
Of the 1031 'random negatives', 199 (19%) were classified after the consensus panel as abnormal by both experts, and another 82 (8%) by one of the experts. They agreed on the presence of an abnormality consistent with TB in 77 (8%; Table 2 Of the 112 radiographs of confirmed TB cases, the κ for inter-expert reader agreement on any abnormality was almost perfect before and after the consensus panel, and for abnormalities consistent with TB increased from 0.74 (95%CI 0.59-0.88) to 0.93 (95%CI 0.84-1.00; Table 2 ). Table 2 . Agreement between experts on any abnormality and abnormality consistent with PTB in the randomly selected radiographs* and in the radiographs of persons with PTB Before or after consensus panel Among the 1031 'random negatives' agreement between the classifications of each of the three clinical officers and 'any abnormality' classified by at least one of the experts was moderate, with small differences for each individual clinical officer (Table 3) . (Table 4) . Table 4 . 
Sensitivity and specificity
The sensitivity of the clinical officer readings (all three combined) in classifying CXRs of bacteriologically confirmed TB cases as abnormal was 95% (95%CI 89-98). For the expert readings prior to the consensus panel these were 83% (95%CI 75-89) and 81%
(95% CI 73-88) respectively when any abnormality was considered. Considering only abnormalities consistent with TB further reduced the sensitivity, but had the highest specificity: respectively 87% (95%CI 85-89) and 92% (95%CI 90-94; Table 5 
estimating missed cases by clinical officers
Of the 652 CXRs of non-suspects in the randomly selected CXRs, 24 (3.7%; 95%CI 2.2-5.1) were classified by at least one of the experts as having an abnormality consistent with TB and 13 (2.0%; 95% CI 0.9-3.1) by both experts, after the consensus panel. 
DISCuSSIOn
The sensitivity of the clinical officers' detection of abnormalities on CXRs of bacteriologically confirmed cases was 95%. The underestimation of prevalence due to CXR screening by clinical officers was in the range of 1.5-5.0%, based on a review of a random sample of CXRs by two experts followed by a consensus debate.
The uncertainty range of the prevalence underestimation decreased after the consensus panel, and could have been further reduced by a third expert referee reader and by a larger random sample of CXRs for expert reading. However the uncertainty range of 1.5%-5.0% is small compared to the 95% CI of the overall prevalence estimate of the survey, determined by the overall survey design, which was ±23% of the point estimate.
The high sensitivity of the clinical officers in classifying CXRs of confirmed TB cases as abnormal was reassuring, as were the levels of inter-reader agreement. 11, 15 The lower sensitivity of the experts is in line with other reports, also considering an expected reduced sensitivity in this high HIV prevalence population. [16] [17] [18] [19] The clinical officers were trained to recognize common abnormalities, consider a CXR abnormal in case of doubt, and to consider all abnormalities regardless of their possible relevance for TB. This resulted in low specificity (71%), also reported in mass screening campaigns and in the clinical TB diagnostic process. [16] [17] [18] [19] Consequently, a large proportion of survey participants requires culture, which has considerable logistical and cost implications. From our data, CXR screening by experts would have increased specificity above 90% if only those abnormalities consistent with TB were considered. However, sensitivity would decrease to below 80%, resulting in a larger underestimation of prevalence.
As the availability of physicians for TB diagnosis in clinical settings is limited in several African countries, CXRs reading by clinical officers or other cadres of health worker could also be applied to select suspects for further bacteriological examination with newer rapid, sensitive, but still expensive diagnostic test like GenXpert (Cepheid, Sunnyvale, CA, USA). 20 A potential concern is confusion between sensitive reading for screening purposes with the more specific approach for clinical diagnosis of smear-negative TB in absence of additional bacteriological testing, to limit false-positive diagnoses; this limitation could, however, be addressed by training, supervision, quality assurance and operations research.
Our method of estimating missed cases has not been evaluated in a survey where all participants had sputum culture and CXRs read by multiple experts and clinical officers.
We may have overestimated sensitivity and underestimated missed cases, due either to cases being missed by the study design, as smear-negative culture-positive TB cases with negative symptoms and CXR on screening were not captured by our survey, or to falsepositive TB diagnosis in asymptomatic participants with an 'over-read' CXR abnormality.
There were few of the latter, however. CXR reading by experts had 97% sensitivity (95%CI 90-100) in a survey conducted in Cape Town
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, where all participants were eligible for CXR and sputum culture. Conversely, our assumption that, among participants with a negative symptom screen, the prevalence of smear-negative culture-positive TB was similar in participants whose abnormalities were missed and in those whose abnormalities were not missed may overstate the estimate of missed cases. Missed abnormalities may be less severe and less likely be associated with bacteriologically active TB than more pronounced abnormalties. 21, 22 The interpretation of the reported κ statistic requires some caution, as it is influenced by the prevalence of the assessed condition. 23 
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Other aspects that could be improved include reading of a standard set of CXRs by experts, as is done in the case of the International Labour Organization. 8 The clinical officers were trained with a set of CXRs prepared by the radiologist, but the experts did not review the same set. The optimal reporting form also remains to be determined. The CRRS form, developed for community surveys, 11 allows for detailed reporting, which may increase specificity, but also requires more time than the simpler classification used by the clinical officers. We used conventional radiography in our survey. Digital equipment could make training and supervision easier, in particular if communication with offsite experts is available. Digital equipment also allows the evaluation of computerised systems to assess CXR abnormalities 24 for their usefulness in prevalence surveys.
Ultimately, a simple diagnostic test would eliminate the need for screening CXRs.
However, in the interim, an acceptable level of CXR screening for 'any abnormality' can be achieved by clinical officers, with sufficient training and standard operating procedures to maintain quality of CXR reading. The degree to which prevalence is underestimated can be assessed by review of a sample of CXRs by two experts. We recommend this approach for TB prevalence surveys planned in similar settings and further evaluation of clinical applicability in combination with new bacteriological tests.
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